A $3.5 million research project that will study the long-term benefits and risks of implantable cardioverter defibrillators  (ICDs) in patients at risk of death from ventricular fibrillation will be supported by the Department of Health & Human Services’ (HHS) Agency for Healthcare Research and Quality (AHRQ) and the American College of Cardiology (ACC). The project is being conducted in cooperation with the National Heart, Lung and Blood Institute and will follow 3500 patients with ICDs from the cardiovascular Research Network.

More information is available at http://www.ahrq.gov/news/press/pr2010/accicdpr.htm

This entry was posted on Friday, January 29th, 2010 at 4:21 pm and is filed under Medical Reimbursement News. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.